The effect of systemic zonisamide (Zonegran™) on thermal hyperalgesia and mechanical allodynia in rats with an experimental mononeuropathy

Anesthesia and Analgesia

Volumn 96, Issue 6, 2003, Pages 1700-1706

  Hord, Allen H ^a   Denson, Donald D ^a   Chalfoun, Amale G ^a   Azevedo, M Isabel ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZONISAMIDE;

ALLODYNIA; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HYPERALGESIA; MALE; MONONEUROPATHY; NEUROPATHIC PAIN; NONHUMAN; PAIN ASSESSMENT; POSTOPERATIVE CARE; PRIORITY JOURNAL; RAT; THERMAL INJURY;

EID: 0038024328     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000062652.66661.97     Document Type: Article

References (31)

1. Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 1999;83:389-400.
2. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999;353:1959-64.
3. Woolf CJ, Decosterd I. Implications of recent advances in the understanding of pain pathophysiology for the assessment of pain in patients. Pain 1999;Suppl 6:S141-7.
4. Vaillancourt PD, Langevin HM. Painful peripheral neuropathies. Med Clin North Am 1999;83:627-42.
5. Rowbotham MC, Petersen KL, Davies PS, et al. Recent developments in the treatment of neuropathic pain. In: Devor M, Rowbotham MC, Wiesenfeld-Hallin Z, eds. Proceedings of the 9th World Congress on Pain: progress in pain research and management. Seattle: ISAP Press, 2000:833-55.
6. Backonja M-M. Anticonvulsants (antineuropathics) for neuropathic pain syndromes. Clin J Pain 2000;16(Suppl 2):S67-72.
7. 2δ subunit of a calcium channel. J Biol Chem 1996;271:5768-76.
8. Ross EL. The evolving role of antiepileptic drugs in treating neuropathic pain. Neurology 2000;55(Suppl 1):S41-6.
9. Burchiel KJ. Carbamazepine inhibits spontaneous activity in experimental neuromas. Exp Neurol 1988;102:249-53.
10. Campbell FG, Graham JG, Zilkha KJ. Clinical trial of carbazepine (Tegretol) in trigeminal neuralgia. J Neurol Neurosurg Psychiatry 1966;29:265-7.
11. Rull JA, Quibrera R, González-Millán H, et al. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol®): double blind crossover trial. Diabetologia 1969;5:215-8.
12. MacFarlane BV, Wright A, O'Callaghan J, et al. Chronic neuropathic pain and its control by drugs. Pharmacol Ther 1997;75:1-19.
13. Chabal C, Jacobson L, Mariano A, et al. The use of oral mexiletine for the treatment of pain after peripheral nerve injury. Anesthesiology 1992;76:513-7.
14. Dejgard A, Petersen P, Kastrup J. Mexiletine for treatment of chronic painful diabetic neuropathy. Lancet 1988;1:9-11.
15. Peters DH, Sorkin EM. Zonisamide: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy. Drugs 1993;45:760-87.
16. Bennett GJ, Xie Y-K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988;33:87-107.
17. Hargreaves K, Dubner R, Brown F, et al. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988;32:77-88.
18. Brennan TJ, Vandermeulen EP, Gebhart GF. Characterization of a rat model of incisional pain. Pain 1996;64:493-501.
19. Baron R. Peripheral neuropathic pain: from mechanisms to symptoms. Clin J Pain 2000;16(Suppl 2):S12-20.
20. Cummins TR, Dib-Hajj SD, Black JA, et al. Sodium channels and the molecular pathophysiology of pain. Prog Brain Res 2000;129:3-19.
21. Dib-Hajj SD, Fjell J, Cummins TR, et al. Plasticity of sodium channel expression in DRG neurons in the chronic constriction injury model of neuropathic pain. Pain 1999;83:591-600.
22. Antkiewicz-Michaluk L. Receptor and voltage-operated ion channels in the central nervous system. Pol J Pharmacol 1995;47:253-64.
23. Erichsen HK, Blackburn-Munro G. Pharmacological characterisation of the spared nerve injury model of neuropathic pain. Pain 2002;98:151-61.
24. Bennett GJ. Neuropathic pain: new insights, new interventions. Hosp Pract 1998;33:95-114.
25. Christensen D, Kayser V. The development of pain-related behaviour and opioid tolerance after neuropathy-inducing surgery and sham surgery. Pain 2000;88:231-8.
26. Bennett GJ. An animal model of neuropathic pain: a review. Muscle Nerve 1993;16:1040-8.
27. Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology 1997;48:332-8.
28. Bennett GJ. New frontiers in mechanisms and therapy of painful peripheral neuropathies. Acta Anaesthesiol Sin 1999;37:197-203.
29. Munger BL, Bennett GJ, Kajander KC. An experimental painful peripheral neuropathy due to nerve constriction. I. Axonal pathology in the sciatic nerve. Exp Neurol 1992;118:204-14.
30. Thomas PK. Pain in peripheral neuropathy: clinical and morphological aspects. In: Ochoa J, Culp W, eds. Abnormal nerves and muscles as impulse generators. New York: Oxford University Press, 1982:553-67.
31. Baron R, Haendler G, Schulte H. Afferent large fiber polyneuropathy predicts the development of postherpetic neuralgia. Pain 1997;73:231-8.